| 2018/01/07 |  |
Overseas Regulatory Announcement
|
| 2018/01/07 | |
Overseas Regulatory Announcement
|
| 2018/01/07 | |
Overseas Regulatory Announcement
|
| 2018/01/07 | |
OVERSEAS REGULATORY ANNOUNCEMENT
IN RELATION TO REPLY TO ENQUIRY LETTER
FROM THE SHANGHAI STOCK EXCHANGE
|
| 2018/01/04 | |
Overseas Regulatory Announcement
|
| 2018/01/03 | |
VERY SUBSTANTIAL ACQUISITION
IN RELATION TO THE PROPOSED ACQUISITION OF
30% OF THE EQUITY INTEREST IN GUANGZHOU PHARMACEUTICALS
CORPORATION AND GRANT OF PUT OPTIONS TO
THE VENDOR TO SELL 20% OF THE EQUITY INTEREST IN
GUANGZHOU PHARMACEUTICALS CORPORATION - RECEIPT OF
ENQUIRY LETTER FROM THE SHANGHAI STOCK EXCHANGE
|
| 2018/01/01 | |
Overseas Regulatory Announcement
|
| 2018/01/01 | |
Overseas Regulatory Announcement
|
| 2017/12/26 | |
Overseas Regulatory Announcement
|
| 2017/12/26 | |
Overseas Regulatory Announcement
|
